FDA reviews 2 new drugs to reduce prostate cancer

Nov 29, 2010 By MATTHEW PERRONE , AP Health Writer

(AP) -- Health regulators said Monday that two drugs from GlaxoSmithKline and Merck reduce the risk of prostate cancer in men, though scientists questioned the drugs' overall benefit, since the tumors they prevent are usually not life-threatening.

The reviewers for the Food and Administration also complained that the companies only studied a small number of African Americans, who are at high risk for .

The agency will hold a public meeting on the drugs on Wednesday.

U.K.-based PLC has asked the FDA to approve its drug Avodart for a new use against prostate cancer, after research showed a 23 percent reduction in low-grade prostate tumors among men taking the drug.

Merck & Co. of Whitehouse Station, N.J., achieved similar results with its drug Proscar and is asking the FDA to approve labeling about its drug's benefits in reducing prostate cancer risks. Both drugs are already approved to treat enlarged prostate.

But regulators said in an online review Monday that only a small percentage of patients studied were African Americans, who are at increased risk of the disease.

Only 4 percent of Merck's patients were African American, while Glaxo's trial enrolled just 2 percent African American patients.

"The applicability to African-American men is not known due to marked under-representation," states the FDA's review.

FDA's review also raises broader questions about the value of preventing low-grade tumors. According to the FDA, about 80 percent of the tumors the drugs prevent are not aggressive. Because the tumors grow so slowly, they are not considered a threat to senior men with less than 20 years of life expectancy.

While the tumors may not be life threatening, Glaxo has argued that they can lead to unnecessary treatment and biopsies - a procedure where a tiny tissue sample is removed and tested for cancer. About 650,000 men had prostate biopsies last year and seventy percent of the tumors found were low-grade, according to Glaxo.

Some recent studies have suggested prostate cancer is over-diagnosed and over-treated in men - even in men with low-grade tumors. Treatment for the disease can include surgery to remove a , radiation therapy and chemotherapy.

On Wednesday, the FDA will ask a panel out advisers to vote on whether the safety and effectiveness of Avodart and Proscar in preventing prostate cancer. The agency is not required to follow the panel's advice, though it often does.

Explore further: FDA proposes accelerated medical device approval plan

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Study finds possible heart risk with prostate drug

Mar 31, 2010

(AP) -- Full results of a big study testing a drug for preventing prostate cancer show a higher risk of heart failure, a surprise finding that could dampen enthusiasm for expanding its use.

Recommended for you

FDA proposes accelerated medical device approval plan

Apr 23, 2014

(HealthDay)—The U.S. Food and Drug Administration has proposed a new program that would provide expedited access to high-risk medical devices intended for patients with serious conditions whose medical ...

Targeting drugs to reduce side effects

Apr 23, 2014

(Medical Xpress)—Consider ice cream – the base of which is frozen cream. Ingredients are then added to make different flavours. All these flavours are distinctly different but are created from the same foundation.

User comments : 0

More news stories

Autism Genome Project delivers genetic discovery

A new study from investigators with the Autism Genome Project, the world's largest research project on identifying genes associated with risk for autism, has found that the comprehensive use of copy number variant (CNV) genetic ...

Team reprograms blood cells into blood stem cells in mice

Researchers at Boston Children's Hospital have reprogrammed mature blood cells from mice into blood-forming hematopoietic stem cells (HSCs), using a cocktail of eight genetic switches called transcription factors. The reprogrammed ...

Study links California drought to global warming

While researchers have sometimes connected weather extremes to man-made global warming, usually it is not done in real time. Now a study is asserting a link between climate change and both the intensifying California drought ...